Minireview: Ribonucleic acid interference for the identification of new targets for the treatment of metabolic diseases

Endocrinology

Volumn 147, Issue 6, 2006, Pages 2650-2656

  Rondinone, Cristina M ^a  

^a Hoffmann La Roche ^*  (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GENE PRODUCT; INSULIN; INSULIN RECEPTOR; PHOSPHATIDYLINOSITOL 3 KINASE; RNA;

CAENORHABDITIS ELEGANS; DIABETES MELLITUS; DROSOPHILA; GENE EXPRESSION; GENE IDENTIFICATION; GENE TARGETING; IN VIVO STUDY; MAMMAL CELL; METABOLIC DISORDER; NONHUMAN; OBESITY; PATHOGENESIS; PRIORITY JOURNAL; RNA INTERFERENCE; SHORT SURVEY; SIGNAL TRANSDUCTION; VALIDATION STUDY;

ADENOVIRIDAE; ANIMALS; APOLIPOPROTEINS B; DIABETES MELLITUS; EARLY GROWTH RESPONSE PROTEIN 1; HUMANS; INSULIN; INTERCELLULAR SIGNALING PEPTIDES AND PROTEINS; OBESITY; PHOSPHOPROTEINS; PROTEINS; RNA INTERFERENCE; SIGNAL TRANSDUCTION; TRANSCRIPTION FACTORS;

EID: 33646810093     PISSN: 00137227     EISSN: 00137227     Source Type: Journal    
DOI: 10.1210/en.2006-0147     Document Type: Short Survey

References (69)

1. Meister G, Tuschl T 2004 Mechanisms of gene silencing by double-stranded RNA. Nature 431:343-349
2. Bernstein E, Caudy AA, Hammond SM, Hannon GJ 2001 Role for a bidentate ribonuclease in the initiation step of RNA interference. Nature 409:363-366
3. Zamore PD, Tuschl T, Sharp PA, Bartel DP 2000 RNAi: double-stranded RNA directs the ATP-dependent cleavage of mRNA at 21 to 23 nucleotide intervals. Cell 101:25-33
4. Hammond SM, Bernstein E, Beach D, Hannon GJ 2000 An RNA-directed nuclease mediates post-transcriptional gene silencing in Drosophila cells. Nature 404:293-296
5. Nykanen A, Haley B, Zamore PD 2001 ATP requirements and small interfering RNA structure in the RNA interference pathway. Cell 107:309-321
6. Elbashir SM, Lendeckel W, Tuschl T 2001 RNA interference is mediated by 21- and 22-nucleotide RNAs. Genes Dev 15:188-200
7. Elbashir SM, Martinez J, Patkaniowska A, Lendeckel W, Tuschl T 2001 Functional anatomy of siRNAs for mediating efficient RNAi in Drosophila melanogaster embryo lysate. EMBO J 20:6877-6888
8. Sasaki T, Shiohama A, Minoshima S, Shimizu N 2003 Identification of eight members of the Argonaute family in the human genome small star, filled. Genomics 82:323-330
9. Williams RW, Rubin GM 2002 ARGO-NAUTE1 is required for efficient RNA interference in Drosophila embryos. Proc Natl Acad Sci USA 99:6889-6894
10. Martinez J, Patkaniowska A, Urlaub H, Luhrmann R, Tuschl T 2002 Single-stranded antisense siRNAs guide target RNA cleavage in RNAi. Cell 110:563-574
11. Bartel DP 2004 MicroRNAs: genomics, biogenesis, mechanism, and function. Cell 116:281-297
12. Grishok A, Pasquinelli AE, Conte D, Li N, Parrish S, Ha I, Baillie DL, Fire A, Ruvkun G, Mello CC 2001 Genes and mechanisms related to RNA interference regulate expression of the small temporal RNAs that control C. elegans developmental timing. Cell 106:23-34
13. Hutvagner G, McLachlan J, Pasquinelli AE, Balint E, Tuschl T, Zamore PD 2001 A cellular function for the RNA-interference enzyme Dicer in the maturation of the let-7 small temporal RNA. Science 293:834-838
14. Ketting RF, Fischer SE, Bernstein E, Sijen T, Hannon GJ, Plasterk RH 2001 Dicer functions in RNA interference and in synthesis of small RNA involved in developmental timing in C. elegans. Genes Dev 15:2654-2659
15. Bartel DP, Chen CZ 2004 Micromanagers of gene expression: the potentially widespread influence of metazoan microRNAs. Nat Rev Genet 5:396-400
16. Doench JG, Petersen CP, Sharp PA 2003 siRNAs can function as miRNAs. Genes Dev 17:438-442
17. Hutvagner G, Zamore PD 2002 A microRNA in a multiple-turnover RNAi enzyme complex. Science 297:2056-2060
18. Saltiel AR, Kahn CR 2001 Insulin signalling and the regulation of glucose and lipid metabolism. Nature 414:799-806
19. Saltiel AR 2001 New perspectives into the molecular pathogenesis and treatment of type 2 diabetes. Cell 104:517-529
20. White MF 1998 The IRS-signalling system: a network of docking proteins that mediate insulin action. Mol Cell Biochem 182:3-11
21. Clemens JC, Worby CA, Simonson-Leff N, Muda M, Maehama T, Hemmings BA, Dixon JE 2000 Use of double-stranded RNA interference in Drosophila cell lines to dissect signal transduction pathways. Proc Natl Acad Sci USA 97: 6499-6503
22. Biggs III WH, Zipursky SL 1992 Structure, expression, and signal-dependent tyrosine phosphorylation of a Drosophila homolog of extracellular signal-regulated kinase. Proc Natl Acad Sci USA 89:6295-6299
23. Li J, DeFea K, Roth RA 1999 Modulation of insulin receptor substrate-1 tyrosine phosphorylation by an Akt/phosphatidylinositol 3-kinase pathway. J Biol Chem 274:9351-9356
24. Ogg S, Ruvkun G 1998 The C. elegans PTEN homolog, DAF-18, acts in the insulin receptor-like metabolic signaling pathway. Mol Cell 2:887-893
25. Paradis S, Ruvkun G 1998 Caenorhabditis elegans Akt/PKB transduces insulin receptor-like signals from AGE-1 PI3 kinase to the DAF-16 transcription factor. Genes Dev 12:2488-2498
26. Schaeffer HJ, Weber MJ 1999 Mitogen-activated protein kinases: specific messages from ubiquitous messengers. Mol Cell Biol 19:2435-2444
27. Bohni R, Riesgo-Escovar J, Oldham S, Brogiolo W, Stocker H, Andruss BF, Beckingham K, Hafen E 1999 Autonomous control of cell and organ size by CHICO, a Drosophila homolog of vertebrate IRS1-4. Cell 97:865-875
28. Maehama T, Dixon JE 1999 PTEN: a tumour suppressor that functions as a phospholipid phosphatase. Trends Cell Biol 9:125-128
29. Hsieh AC, Bo R, Manola J, Vazquez F, Bare O, Khvorova A, Scaringe SA, Sellers W 2004 A library of siRNA duplexes targeting the phosphoinositide 3-kinase pathway: determinants of gene silencing for use in cell-based screens. Nucleic Acids Res 32:893-901
30. Cantley LC 2002 The phosphoinositide 3-kinase pathway. Science 296:1655-1657
31. Williams MR, Arthur JS, Balendran A, van der Kaay J, Poli V, Cohen P, Alessi DR 2000 The role of 3-phosphoinositide-dependent protein kinase 1 in activating AGC kinases defined in embryonic stem cells. Curr Biol 10:439-448
32. Jiang ZY, Zhou QL, Coleman KA, Chouinard M, Boese Q, Czech MP 2003 Insulin signaling through Akt/protein kinase B analyzed by small interfering RNA-mediated gene silencing. Proc Natl Acad Sci USA 100:7569-7574
33. Elbashir SM, Harborth J, Lendeckel W, Yalcin A, Weber K, Tuschl, T 2001 Duplexes of 21-nucleotide RNAs mediate RNA interference in cultured mammalian cells. Nature 411:494-498
34. Zhou QL, Park JG, Jiang ZY, Holik JJ, Mitra P, Semiz S, Guilherme A, Powelka AM, Tang X, Virbasius J, Czech MP 2004 Analysis of insulin signalling by RNAi-based gene silencing. Biochem Soc Trans 32:817-821
35. Mitra P, Zheng X, Czech MP 2004 RNAi-based analysis of CAP, Cbl, and CrkII function in the regulation of GLUT4 by insulin. J Biol Chem 279:37431-37435
36. Katome T, Obata T, Matsushima R, Masuyama N, Cantley LC, Gotoh Y, Kishi K, Shiota H, Ebina Y 2003 Use of RNA interference-mediated gene silencing and adenoviral overexpression to elucidate the roles of AKT/protein kinase B isoforms in insulin actions. J Biol Chem 278:28312-28323
37. Huang C, Thirone AC, Huang X, Klip A 2005 Differential contribution of insulin receptor substrates 1 versus 2 to insulin signaling and glucose uptake in l6 myotubes. J Biol Chem 280:19426-19435
38. Ashrafi K, Chang FY, Watts JL, Fraser AG, Kamath RS, Ahringer J, Ruvkun G 2003 Genome-wide RNAi analysis of Caenorhabditis elegans fat regulatory genes. Nature 421:268-272
39. Hamilton B, Dong Y, Shindo M, Liu W, Odell I, Ruvkun G, Lee SS 2005 A systematic RNAi screen for longevity genes in C. elegans. Genes Dev 19:1544-1555
40. Powelka AM, Seth A, Virbasius JV, Kiskinis E, Nicoloro SM, Guilherme A, Tang X, Straubhaar J, Cherniack AD, Parker MG, Czech MP 2006 Suppression of oxidative metabolism and mitochondrial biogenesis by the transcriptional corepressor RIP140 in mouse adipocytes. J Clin Invest 116:125-136
41. Leonardsson G, Jacobs MA, White R, Jeffrey R, Poulsom R, Milligan S, Parker M 2002 Embryo transfer experiments and ovarian transplantation identify the ovary as the only site in which nuclear receptor interacting protein 1/RIP140 action is crucial for female fertility. Endocrinology 143:700-707
42. Leonadsson G, Steel JH, Christian M, Pocock V, Milligan S, Bell J, So PW, Median-Gomez G, Vidal-Puig A, White R, Parker MG 2004 Nuclear receptor corepressor RIP140 regulates fat accumulation. Proc Natl Acad Sci USA 101: 8437-8442
43. Rondinone CM, Haasch D, Clampit J, Pederson T, Frost L, Kroeger P, Trevillyan J, Reilly R 2004 Elucidation of signaling pathways leading to insulin resistance in hepatocytes using small interfering RNA-mediated gene silencing. Diabetes 53(Suppl 2):A315 (Abstract)
44. White MF 2002 IRS proteins and the common path to diabetes. Am J Physiol 283:E413-E422
45. Pederson TM, Kramer DL, Rondinone CM 2001 Serine/threonine phosphorylation of IRS-1 triggers its degradation: possible regulation by tyrosine phosphorylation. Diabetes 50:24-31
46. Garnett KE, Chapman P, Chambers JA, Waddell ID, Boam DS 2005 Differential gene expression between Zucker fatty rats and Zucker Diabetic fatty rats: a potential role for the immediate-early gene Egr-1 in regulation of β cell proliferation. J Mol Endocrinol 35:13-25
47. Taniguchi CM, Ueki K, Kahn CR 2005 Complementary roles of IRS-1 and IRS-2 in the hepatic regulation of metabolism. J Clin Invest 115:718-727
48. Koo SH, Satoh H, Herzig S, Lee CH, Hedrick S, Kulkarni R, Evans RM, Olefsky J, Montminy M 2004. PGC-1 promotes insulin resistance in liver through PPAR-α-dependent induction of TRB-3. Nat Med 10:530-534
49. Yoon J, Puigserver P, Chen G, Donovan J, Wu Z, Rhee J, Adelmant G, Stafford J, Kahn CR, Granner DK, Newgard CB, Spiegelman BM 2001 Control of hepatic gluconeogenesis through the transcriptional coactivator PGC-1. Nature 413:131-138
50. Du K, Herzig S, Kulkarni RN, Montminy M 2003 TRB-3: a tribbles homolog that inhibits Akt/PKB activation by insulin in liver. Science 300:1574-1577
51. Gomez-Valades AG, Vidal-Alabro A, Molas M, Boada J, Bermudez J, Bartrons R, Perales JC 2006 Overcoming diabetes-induced hyperglycemia through inhibition of hepatic phosphoenolpyruvate carboxykinase (GTP) with RNAi. Mol Ther 13:401-410
52. Soutschek J, Akinc A, Bramlage B, Charisse K, Constien R, Donoghue M, Elbashir S, Geick A, Hadwiger P, Harborth J, John M, Kesavan V, Lavine G, Pandey RK, Racie T, Rajeev KG, Rohl I, Toudjarska I, Wang G, Wuschko S, Bumcrot D, Koteliansky V, Limmer S, Manoharan M, Vornlocher HP 2004 Therapeutic silencing of an endogenous gene by systemic administration of modified siRNAs. Nature 432:173-178
53. Burnett JR, Barrett PH 2002. Apolipoprotein B metabolism: tracer kinetics, models, and metabolic studies. Crit Rev Clin Lab Sci 39:89-137
54. Brown MS, Goldstein JL 1986 A receptor-mediated pathway for cholesterol homeostasis. Science 232:34-47
55. Farese Jr RV, Ruland SL, Flynn LM, Stokowski RP, Young SG 1995 Knockout of the mouse apolipoprotein B gene results in embryonic lethality in homozygotes and protection against diet-induced hypercholesterolemia in heterozygotes. Proc Natl Acad Sci USA 92:1774-1778
56. Makimura H, Mizuno TM, Mastaitis JW, Agami R, Mobbs CV 2002 Reducing hypothalamic AGRP by RNA interference increases metabolic rate and decreases body weight without influencing food intake. BMC Neurosci 3:18
57. Ollmann MM, Wilson BD, Yang YK, Kerns JA, Chen Y, Gantz I, Barsh GS 1997 Antagonism of central melanocortin receptors in vitro and in vivo by agouti-related protein. Science 278:135-138
58. Fan W, Boston BA, Kesterson RA, Hruby VJ, Cone RD 1997 Role of melanocortinergic neurons in feeding and the agouti obesity syndrome. Nature 385:165-168
59. Persengiev SP, Zhu X, Green MR 2004 Nonspecific, concentration-dependent stimulation and repression of mammalian gene expression by small interfering RNAs (siRNAs). RNA 10:12-18
60. Jackson AL, Bartz SR, Schelter J, Kobayashi SV, Burchard J, Mao M, Li B, Cavet G, Linsley PS 2003 Expression profiling reveals off-target gene regulation by RNAi. Nat Biotechnol 21:635-637
61. Saxena S, Jonsson ZO, Dutta A 2003 Small RNAs with imperfect match to endogenous mRNA repress translation. Implications for off-target activity of small inhibitory RNA in mammalian cells. J Biol Chem 278:44312-44319
62. Ma Z, Li J, He F, Wilson A, Pitt B, Li S 2005 Cationic lipids enhance siRNA-mediated interferon response in mice. Biochem Biophys Res Commun 330: 755-759
63. Hornung V, Guenthner-Biller M, Bourquin C, Ablasser A, Schlee M, Uematsu S, Noronha A, Manoharan M, Akira S, de Fougerolles A, Endres S, Hartmann G 2005 Sequence-specific potent induction of IFN-α by short interfering RNA in plasmacytoid dendritic cells through TLR7. Nat Med 11: 263-270
64. Sioud M, Sorensen D 2003 Cationic liposome-mediated delivery of siRNAs in adult mice. Biochem Biophys Res Commun 312:1220-1225
65. Lorenz C, Hadwiger P, John M, Vornlocher H, Unverzagt C 2004 Steroid and lipid conjugates of siRNAs to enhance cellular uptake and gene silencing in liver cells. Bioorg Med Chem Lett 14:4975-4977
66. Schiffelers R, Ansari A, Xu J, Zhou Q, Tang Q, Storm G, Molema G, Lu P, Scaria P, Woodle M 2004 Cancer siRNA therapy by tumor selective delivery with ligand-targeted sterically stabilized nanoparticle. Nucleic Acids Res 32: e149
67. Urban-Klein B, Werth S, Abuharbeid S, Czubayko F, Aigner A 2005 RNAi-mediated gene-targeting through systemic application of polyethylenimine (PEI)-complexed siRNA in vivo. Gene Ther 12:461-466
68. Pardridge W 2004 Intravenous, non-viral RNAi gene therapy of brain cancer. Expert Opin Biol Ther 4:1103-1113
69. Song E, Zhu P, Lee S, Chowdhury D, Kussman S, Dykxhoorn D, Feng Y, Palliser D, Weiner D, Shankar P, Marasco W, Lieberman J 2005 Antibody mediated in vivo delivery of small interfering RNAs via cell-surface receptors. Nat Biotechnol 23:709-717